ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.58
0.14%
US Tech 100
17,612.80
0.00%
S&P 500
5,187.70
0.13%
US Dollar vs CAD
1.37519
0.13%
Bitcoin
62,167.69
-0.27%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Cellectis SA (CLLS)

  7. Cellectis SA (CLLS) News

CLLS Cellectis SA

3.10
0.00 (0.00%)
May 07 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Cellectis SA CLLS NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.00 0.00% 3.10 19:00:00
Open Price Low Price High Price Close Price Previous Close
3.10
more quote information »

Recent News

Date Time Source Heading
5/06/202405:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
5/06/202401:00GLOBECellectis Announces Completion of the Additional Equity..
5/02/202415:30GLOBECellectis Appoints Arthur Stril as Interim Chief Financial..
4/29/202415:46GLOBECellectis Reports Financial Results for the Fourth Quarter..
4/22/202415:30GLOBECellectis Presents Novel TALEN® Editing Processes Enabling..
4/10/202415:30GLOBECellectis Publishes a Novel Intronic Gene Editing Approach..
4/08/202415:30GLOBECellectis Announces Two Poster Presentations on Novel TALEN®..
1/16/202415:45EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
1/16/202415:30GLOBECellectis announces the drawdown of the second tranche of..
12/22/202315:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/22/202315:30GLOBECellectis Reports Results from Shareholders Meeting Held on..
12/22/202315:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/05/202315:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/17/202315:56EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/17/202315:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/17/202315:30GLOBECellectis’ Shareholders Meeting to be Held on December 22,..
11/15/202306:48EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/15/202301:30GLOBECellectis Announces the execution of the Subsequent..
11/09/202315:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/06/202315:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/06/202315:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/06/202315:30GLOBECellectis Reports Financial Results for Third Quarter and..
11/02/202315:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/02/202315:30GLOBECellectis to Present Preliminary Results of NATHALI_01 and..
11/01/202315:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/01/202315:30GLOBECellectis to Report Third Quarter 2023 Financial Results on..
11/01/202314:15APSBiotech Shares Soar After AstraZeneca Stake & Research..
11/01/202306:52DJNCellectis Shares Soar Premarket on AstraZeneca Deal
11/01/202306:51DJNCellectis Shares Soar Premarket on AstraZeneca Deal
11/01/202305:44EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/01/202303:17DJNAstraZeneca to Invest $245 Million in Deal With Cellectis
11/01/202302:00GLOBECellectis Announces Strategic Collaboration and Investment..
10/31/202316:10EDGAR2Form 20-F/A - Annual and transition report of foreign..
10/31/202316:09EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/31/202315:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/31/202315:30GLOBECellectis Presents Pre-Clinical Data on Multi-armored..
10/24/202315:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/12/202315:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/12/202315:30GLOBECellectis and Imagine Institute Publish A Proof-Of-Concept..
9/27/202315:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
9/27/202315:30GLOBECellectis to Present Pre-Clinical Data on Multi-armored..
9/05/202315:32EDGAR2Form 6-K/A - Report of foreign issuer [Rules 13a-16 and..
8/07/202316:05EDGAR2Form S-8 - Securities to be offered to employees in employee..
8/07/202315:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/07/202315:30GLOBECellectis Provides Full Report for Second Quarter 2023..
8/07/202315:17EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/03/202315:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/03/202315:30GLOBECellectis Provides Business Updates and Preliminary..
7/27/202315:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
7/27/202315:30GLOBECellectis to Report Second Quarter 2023 Financial Results on..

Your Recent History

NASDAQ
CLLS
Cellectis
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved